Keiko Yoshimoto, PhD (she/her/hers)

Research Associate
Keio University School of Medicine
Tokyo, Japan

Disclosure information not submitted.

Presentation(s):

• Signaling pathways via BAFF receptor/Nav1.7 channel contribute to the activation of monocytes and B cells in patients with Sjögren’s disease.

  Saturday, April 18, 2026
  1:45 PM - 1:57 PM US ET